ÂÜÀòÂÒÂ×

Amr Morsy serves as the Chief Executive Officer and Board Member of Rameda Pharmaceuticals since January 2011, leading a team of over 2,000 employees to navigate significant challenges in the Egyptian market. Under Amr Morsy's leadership, Rameda emerged as the fastest-growing local pharmaceutical player from 2011 to 2018 and successfully listed on the Egyptian Stock Exchange in December 2019 with a market capitalization of USD 232 million. Prior to Rameda, Amr Morsy held the position of Chairman and Managing Director for Egypt and Sudan at Pfizer, contributing 17 years to various roles within the company. Academic credentials include a Graduate Diploma in Business Administration from Harvard Business School, an MBA from the Arab Academy for Science, Technology and Maritime Transport, and a Bachelor of Pharmacy from Alexandria University. Amr Morsy is committed to creating sustainable value aligned with the UN Sustainable Development Goals, particularly in diversity and inclusion, health, responsible consumption, and clean energy.